Bei Wang

1.2k total citations · 2 hit papers
26 papers, 631 citations indexed

About

Bei Wang is a scholar working on Surgery, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Bei Wang has authored 26 papers receiving a total of 631 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 5 papers in Physiology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Bei Wang's work include Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Nutrition and Health in Aging (4 papers). Bei Wang is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Nutrition and Health in Aging (4 papers). Bei Wang collaborates with scholars based in China, United States and Australia. Bei Wang's co-authors include Michelle L. O’Donoghue, Dan Atar, Marc S. Sabatine, Anthony Keech, Robert P. Giugliano, J. Antonio G. López, Maria Laura Monsalvo, Mary Elliott‐Davey, Julia Kuder and Steven E. Nissen and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Bei Wang

24 papers receiving 624 citations

Hit Papers

Effect of Evolocumab on Coronary Plaque Phenotype and Bur... 2022 2026 2023 2024 2022 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction
    2022 243 citations Stephen J. Nicholls, Yu Kataoka et al. JACC. Cardiovascular imaging profile →
  2. Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
    2022 211 citations Michelle L. O’Donoghue, Robert P. Giugliano et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bei Wang China 8 515 153 121 102 95 26 631
Deborah N. Kalkman Netherlands 12 427 0.8× 75 0.5× 318 2.6× 79 0.8× 67 0.7× 37 652
Sandra N. Verhagen Netherlands 7 430 0.8× 74 0.5× 338 2.8× 97 1.0× 56 0.6× 7 598
Abhishek Mewada United States 2 414 0.8× 128 0.8× 119 1.0× 225 2.2× 51 0.5× 3 604
Ioanna Gouni-Berthold Germany 4 358 0.7× 155 1.0× 61 0.5× 108 1.1× 89 0.9× 6 599
Yong‐Joon Lee South Korea 10 357 0.7× 118 0.8× 154 1.3× 92 0.9× 26 0.3× 43 464
P.J. Barter Australia 9 539 1.0× 43 0.3× 167 1.4× 300 2.9× 88 0.9× 13 742
Andrea Ruzza United States 17 830 1.6× 223 1.5× 279 2.3× 145 1.4× 78 0.8× 45 980
Adam Sukiennik Poland 12 315 0.6× 48 0.3× 327 2.7× 149 1.5× 47 0.5× 66 639
Maximilian Brockmeyer Germany 10 358 0.7× 136 0.9× 249 2.1× 72 0.7× 43 0.5× 28 600
Hendrik du Toit Theron United States 5 517 1.0× 80 0.5× 229 1.9× 222 2.2× 45 0.5× 6 597

Countries citing papers authored by Bei Wang

Since Specialization
Citations

This map shows the geographic impact of Bei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bei Wang more than expected).

Fields of papers citing papers by Bei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bei Wang. The network helps show where Bei Wang may publish in the future.

Co-authorship network of co-authors of Bei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Bei Wang. A scholar is included among the top collaborators of Bei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bei Wang. Bei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Donoghue, Michelle L., Xinhui Ran, Sabina A. Murphy, et al.. (2025). Long-Term Lipid Lowering With Evolocumab in Older Individuals. Journal of the American College of Cardiology. 85(5). 504–512. 4 indexed citations
2.
Shan, Shuang, Zihao Ou, Hongli Fu, et al.. (2025). Detection of virulence genes in Helicobacter pylori and its correlation with drug resistance by polymerase chain reaction. European journal of medical research. 30(1). 523–523.
3.
4.
Zimerman, André, Michelle L. O’Donoghue, Xinhui Ran, et al.. (2024). Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab. NEJM Evidence. 4(1). EVIDoa2400112–EVIDoa2400112. 6 indexed citations
5.
O’Donoghue, Michelle L., Gaetano Maria De Ferrari, Jorge Ferreira, et al.. (2024). Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease. Journal of the American College of Cardiology. 83(6). 652–664. 10 indexed citations
6.
7.
Sheng, Ming, et al.. (2023). Research trends in cardiovascular tissue engineering from 1992 to 2022: a bibliometric analysis. Frontiers in Cardiovascular Medicine. 10. 1208227–1208227. 3 indexed citations
8.
O’Donoghue, Michelle L., Robert P. Giugliano, Stephen D. Wiviott, et al.. (2022). Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease. Circulation. 146(15). 1109–1119. 211 indexed citations breakdown →
9.
Chan, Kai Siang, et al.. (2022). Outcomes of an outpatient home-based prehabilitation program before pancreaticoduodenectomy: A retrospective cohort study. Annals of Hepato-Biliary-Pancreatic Surgery. 26(4). 375–385. 7 indexed citations
10.
Nicholls, Stephen J., Yu Kataoka, Steven E. Nissen, et al.. (2022). Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction. JACC. Cardiovascular imaging. 15(7). 1308–1321. 243 indexed citations breakdown →
11.
Santos, Raúl D., Andrea Ruzza, G. Kees Hovingh, et al.. (2022). Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT. The Lancet Diabetes & Endocrinology. 10(10). 732–740. 32 indexed citations
12.
13.
Abulizi, Abudukadier, Rebecca Cardone, Romana Stark, et al.. (2020). Multi-Tissue Acceleration of the Mitochondrial Phosphoenolpyruvate Cycle Improves Whole-Body Metabolic Health. Cell Metabolism. 32(5). 751–766.e11. 55 indexed citations
14.
Zhao, Qing, Jing Wei, Chen‐Yu Zhang, et al.. (2019). Large-cell neuroendocrine carcinoma of nasal cavity and paranasal sinuses after successful curative therapy: a case report and literature review. SHILAP Revista de lepidopterología.
15.
16.
17.
Wang, Bei, et al.. (2018). Early diagnostic potential of APC hypermethylation in esophageal cancer. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Wang, Bei, Rongju Sun, Wei Chen, & Tanshi Li. (2017). Enlightenment and lesson from the successful treatment of acute superior mesenteric artery embolism. Cellular and Molecular Biology. 63(11). 23–27. 2 indexed citations
19.
Sun, Zhongquan, et al.. (2015). Hepatolithiasis associated with intrahepatic heterotopic pancreas: a case report and literature review. Diagnostic Pathology. 10(1). 76–76. 2 indexed citations
20.
Nie, Guoxing, Caixia Hou, Junli Wang, et al.. (2011). Molecular cloning and sequence analysis of sglt1 and tertiary structure prediction of deduced protein in Cyprinus carpio L.. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deborah N. Kalkman Breakdown of academic impact, for papers by Sandra N. Verhagen Breakdown of academic impact, for papers by Abhishek Mewada Breakdown of academic impact, for papers by Ioanna Gouni-Berthold Breakdown of academic impact, for papers by Yong‐Joon Lee Breakdown of academic impact, for papers by P.J. Barter Breakdown of academic impact, for papers by Andrea Ruzza Breakdown of academic impact, for papers by Adam Sukiennik Breakdown of academic impact, for papers by Maximilian Brockmeyer Breakdown of academic impact, for papers by Hendrik du Toit Theron
Rankless by CCL
2026